Posted inNews and Updates
Breakthrough Oral Insulin Pill Reaches Major Clinical Goal
Researchers have achieved a breakthrough with a new oral insulin pill, potentially eliminating the need for daily injections for diabetes patients.
Posted inNews and Updates
AI-Designed Rentosertib Enters Phase III IPF Trial
The AI-designed drug Rentosertib enters Phase III trials for idiopathic pulmonary fibrosis. Explore how this breakthrough impacts the future of lung disease.
Posted inNews and Updates
The New Era of AI Validation in Clinical Trials
New industry standards for AI validation are transforming clinical trials. Discover how algorithmic rigor is redefining the future of drug development.
Posted inNews and Updates
Teitur Trophics Reports Positive Phase I Trial for TT-P34
Teitur Trophics reports successful Phase I results for TT-P34, a first-in-class peptide therapy showing promise for treating Parkinson's disease.
Posted inNews and Updates
Tyra Biosciences Advances Dabogratinib for Bladder Cancer
Tyra Biosciences selects the 60mg dose of dabogratinib for its Phase 2 NMIBC trial, targeting a new bladder-sparing therapy for BCG-unresponsive patients.
Posted inNews and Updates
Seismic Pharmaceuticals Begins Phase 3 Trial for Istaroxime
Seismic Pharmaceuticals has launched a Phase 3 trial for Istaroxime, a novel therapy targeting cardiogenic shock. Learn about this breakthrough heart trial.
Posted inNews and Updates
AI-Discovered Drug Rentosertib Enters Phase III IPF Trial
Insilico Medicine has launched a Phase III trial for Rentosertib, an AI-discovered drug targeting Idiopathic Pulmonary Fibrosis. See the latest progress here.
Posted inNews and Updates
FDA Grants Priority Review to Roche’s Enspryng for MOGAD
The FDA has granted Priority Review to Roche’s Enspryng for MOGAD. Learn about the trial data and the potential impact on treating this rare neuro-disorder.
Posted inNews and Updates
Humanizing Clinical Trials: The Future of Patient Engagement
Discover how modern clinical trials are shifting toward patient-centric models to improve recruitment, retention, and the success of new drug development.
Posted inNews and Updates
India Approves First Dengue Vaccine: What You Need to Know
India has approved QDENGA, the country's first dengue vaccine. Learn how this tetravalent shot provides protection against all four virus serotypes.